Asthma Intervention Programs for Asthma
(PR-AIR Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve asthma care for children in San Juan, Puerto Rico, where the condition is particularly common. Researchers seek to determine whether in-person or online asthma management education is more effective. Families with children who have poorly controlled asthma will receive hands-on assistance through programs like CASE and HARP (High Intensity package). In contrast, those with less severe cases will receive remote support through programs like CASE-V and HARP-V (Low Intensity package). The trial seeks children aged 2 to 12 living in specific areas of San Juan who struggle with managing their asthma. As an unphased trial, it offers families the opportunity to contribute directly to enhancing asthma care strategies for children in their community.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this intervention program is safe for children with asthma?
Research shows that both the in-person and remote versions of the CASE and HARP programs are safe. The Home Asthma Response Program (HARP) led to a 75% reduction in asthma-related hospital and emergency room costs after one year, indicating fewer severe asthma attacks and suggesting the programs are well-tolerated.
While the remote versions (CASE-V and HARP-V) are newer, studies indicate that remote asthma check-ups can be as effective and safe as in-person visits. This suggests that participants should also tolerate the remote versions well.
Overall, evidence from similar programs like RI-AIR suggests that both in-person and remote interventions are safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about these asthma intervention programs because they offer flexible delivery methods tailored to meet different needs. Unlike traditional asthma treatments that often rely on medication, these programs focus on personalized education and support, which can be delivered either in-person or remotely. The High Intensity package, which includes in-person versions of CASE and HARP, provides a comprehensive approach for families needing hands-on support. Meanwhile, the Low Intensity package, delivered virtually, offers more accessibility for families who prefer remote engagement. This flexibility and personalized approach aim to improve asthma control by addressing specific family dynamics and preferences, potentially leading to better outcomes for children with poorly controlled asthma.
What evidence suggests that this trial's interventions could be effective for asthma?
Research has shown that the Home Asthma Response Program (HARP) helps people manage asthma more effectively. This is evident from an increase in the correct use of asthma medications, rising from 32% to 46%. Simply put, more individuals are taking their medications properly, aiding in the control of asthma symptoms. The CASE program has also succeeded in teaching both children and their caregivers how to manage asthma, leading to better understanding and control of the condition.
In this trial, participants will join different intervention arms. The High Intensity (in-Person) Intervention Implementation arm offers in-person versions of HARP and CASE for families of children with poorly controlled asthma, and an in-person version of CASE for children with not well-controlled asthma. Meanwhile, the Low-Intensity (Virtual) Intervention Implementation arm provides remote versions, CASE-V and HARP-V, aiming to achieve similar success by delivering the same education and support online. This approach reaches more people, especially in communities with high asthma rates, ensuring they receive the support needed to manage asthma effectively.13456Who Is on the Research Team?
Daphne Koinis Mitchell, PhD
Principal Investigator
Rhode Island Hospital
Elizabeth L McQuaid, PhD, ABPP
Principal Investigator
Rhode Island Hospital
Ligia Chavez, PhD
Principal Investigator
University of Puerto Rico
Are You a Good Fit for This Trial?
This trial is for children aged 2-12 with not well controlled or poorly controlled asthma, living in specific areas of San Juan, Puerto Rico. It's not suitable for kids with complex medical conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Phase 1: Formative Evaluation
Researchers collaborate with community stakeholders to identify needs, barriers, and facilitators for PR-AIR implementation.
Phase 2: Low-Intensity Implementation
Families receive virtual interventions for asthma management.
Phase 2: High-Intensity Implementation
Families receive in-person interventions for asthma management.
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- CASE and HARP in person (High Intensity package)
- CASE in person version (High Intensity Package)
- CASE-V and HARP-V remote version (Low Intensity package)
- CASE-V remote version (Low Intensity Package)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rhode Island Hospital
Lead Sponsor
University of Puerto Rico
Collaborator